Totsuka K et al. |
Metabolism of S-1108, a new oral cephem antibiotic, and metabolic profiles of its metabolites in humans. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1503437
|
Nakashima M et al. |
Phase I clinical studies of S-1108: safety and pharmacokinetics in a multiple-administration study with special emphasis on the influence on carnitine body stores. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1503438
|
Shimizu K et al. |
Carnitine status and safety after administration of S-1108, a new oral cephem, to patients. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8517691
|
Mizojiri K et al. |
Disposition of S-1108, a new oral cephem antibiotic, and metabolic fate of pivalic acid liberated from [pivaloyl-14C]S-1108 in rats and dogs. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7492083
|
Probian C et al. |
Anaerobic mineralization of quaternary carbon atoms: isolation of denitrifying bacteria on pivalic acid (2,2-dimethylpropionic acid). |
2003 |
Appl. Environ. Microbiol. |
pmid:12620885
|
Rezanka T et al. |
Biosynthesis and metabolic pathways of pivalic acid. |
2012 |
Appl. Microbiol. Biotechnol. |
pmid:22790609
|
Tamaru RD et al. |
Comparison of ocular disposition of free pivalic acid and pivalic acid esterified in dipivefrin. |
1983 |
Arch. Ophthalmol. |
pmid:6347153
|
Staatz WD et al. |
Cytotoxicity of pivalylphenylephrine and pivalic acid to corneal endothelium. |
1980 |
Arch. Ophthalmol. |
pmid:7396784
|
Wexler BC |
Corticotropin stimulation of hypertensive rats with and without arteriosclerosis. |
1978 |
Arch. Pathol. Lab. Med. |
pmid:214053
|
Zanelli U et al. |
Induction of peroxisomal beta-oxidation and P-450 4A-dependent activities by pivalic and trichloroacetic acid in rat liver and kidney. |
1996 |
Arch. Toxicol. |
pmid:8825670
|